Clinical Trial: Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525089) titled 'Human Clinical Trial to Evaluate the Decolonization Efficacy of BM111 Against Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococcus (VRE)' on March 23.

Brief Summary: A clinical study to eliminate intestinal colonization in subjects harboring microorganisms resistant to carbapenem and vancomycin antibiotics, thereby treating infections caused by these microorganisms.

Study Start Date: March 23

Study Type: INTERVENTIONAL

Condition: VRE Colonization CRE Colonization

Intervention: DIETARY_SUPPLEMENT: BM111

A mixture of four intestinal microorganisms

DIETARY_SUPPLEMENT: Placebo

Placebo; Maltodextr...